GARDEN CITY, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today commented on the publication of an independent review article providing the most comprehensive overview to date of high‑dose inhaled nitric oxide (iNO) delivered at concentrations well above the FDA‑approved 20 ppm, and presenting mounti ...

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today presented data on its novel approach to the use of BiTEs in solid tumors by utilizing its systemically delivered RedTail platform at the AACR Immuno-Oncology (AACR-IO) conference being held in Los Angeles, California. A link to the poster is available here and on the company’s website. RedTail is C ...

TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March. Oppenheimer 36th Annual Healthcare Life Sciences Conference Date and time: February 25, 2026, 1:20 p.m. ETLocation: Virtual (register here: https://event.summitcast.com/view/CTtthLh2Bi2D9 ...

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company”), a self-managed diversified healthcare real estate investment trust focusing on senior housing and outpatient medical facilities, today announced results for the fourth quarter and full year ended December 31, 2025. Michael Anderson, Chief Executive Officer and President, commented, “We are very pleased with the exceptional internal growth of our senior housing portfolio and the steady pe ...

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Society Pass Incorporated (Nasdaq: SOPA) (the “Company”), Southeast Asia’s (SEA) next generation e-commerce ecosystem, and its majority owned subsidiary, NusaTrip Incorporated (Nasdaq: NUTR) (“NusaTrip”), the leading SEA and Asia-Pacific-based (APAC) integrated travel technology platform, announces that NusaTrip filed a Form 8-K with the Securities and Exchange Commission (SEC) on February 3, 2026 regarding the status of trading in NusaTrip’s securities on The Na ...

Core Insights - SeenThis has integrated as a third-party ad-serving solution for delivering ads to Amazon Custom Audiences via secure server-to-server (S2S) integration, enhancing its role in video advertising across the open web [1][2] Group 1: Integration and Capabilities - The S2S integration allows brands to activate Amazon Custom Audiences using SeenThis' high-impact video formats and adaptive streaming technology, extending their audience strategies beyond Amazon.com [2][3] - This integration is already operational, with Stackline being the first partner to run a campaign using SeenThis' server-to-server connection for Amazon Custom Audiences, showcasing the combination of SeenThis's technology and Amazon's audience signals [3] Group 2: Market Potential and Strategy - SeenThis emphasizes the untapped advertising potential of the open web, contrasting it with social platforms that offer scale but may not fully leverage premium publishers [5] - The company aims to build an ecosystem of partnerships to make open web advertising more effective and scalable for brands while ensuring sustainable revenue for publishers [4] Group 3: Company Background and Performance - Since its inception in 2017, SeenThis has served billions of streams for over 5,000 brands across more than 50 countries, demonstrating its capability in delivering effective video advertising [6]

Core Viewpoint - The Issuer has announced amendments to the Severe Disruption Event Threshold for certain classes of ETP Securities, which are not materially prejudicial to the interests of ETP Securityholders [2]. Group 1: Amendments to Severe Disruption Event Threshold - BNP Paribas Financial Markets acts as the Swap Provider for the affected securities and has agreed to amend the Severe Disruption Event Threshold [2]. - The amended thresholds for the affected securities are as follows: - WisdomTree Brent Crude Oil 3x Daily Short: 30% - WisdomTree Natural Gas 3x Daily Short: 30% - WisdomTree WTI Crude Oil: 100% - WisdomTree Brent Crude Oil: 100% [2]. - The effective date of the amendments is the date of the notice [2].

Core Insights - Wrap Technologies, Inc. has launched its second Arrest-in-Control (AIC) training unit as part of its Non-Lethal Response (NLR) platform, enhancing public safety training capabilities [1][6] - The training curriculum was developed in partnership with STORM Training Group, focusing on structured control and stabilization processes following non-lethal engagement [2][5] - The new five-course package is available through WrapTactics™, a subscription-based digital learning ecosystem aimed at improving operational consistency and retention [3][4] Training and Development - The training modules emphasize close-quarters engagement techniques, including BolaWrap integration, to enhance officer safety during dynamic encounters [3][7] - Wrap's LMS supports a blended training model that allows agencies to adapt to staffing and fiscal challenges while enhancing training effectiveness [4][9] - Additional training units are in development to further integrate non-lethal response principles into public safety training [6] Strategic Partnerships - The collaboration with STORM Training Group leverages their expertise in defensive tactics and performance optimization to improve the quality of training content [5][10] - STORM's methodology is expected to enhance the effectiveness of WrapTactics™ by providing a structured framework for training [5] Product Overview - The BolaWrap® device is designed to provide law enforcement with non-lethal options for early intervention in escalating situations, reducing reliance on higher-force options [7][12] - Wrap's product portfolio includes various innovative technologies aimed at improving public safety, such as the WrapReality™ training platform and WrapVision™ body-worn camera system [11][12]

Group 1 - AGF Investments Inc. announced cash distributions for February 2026 for three funds: AGF Enhanced U.S. Equity Income Fund, AGF Total Return Bond Fund, and AGF Systematic Global Infrastructure ETF, with payments scheduled for March 5, 2026 [1] - The cash distribution amounts per unit are as follows: AGF Enhanced U.S. Equity Income Fund at $0.181211, AGF Total Return Bond Fund at $0.092000, and AGF Systematic Global Infrastructure ETF at $0.160670 [1] Group 2 - AGF Management Limited, founded in 1957, is an independent asset management firm with over $59 billion in total assets under management, serving more than 820,000 investors [7] - AGF operates through three business lines: AGF Investments, AGF Capital Partners, and AGF Private Wealth, focusing on responsible and sustainable corporate practices [5][6] - AGF Investments is a group of wholly owned subsidiaries of AGF Management Limited, managing mutual funds in Canada [8][9]

Core Insights - Kane Biotech Inc. has published an article on its revyve Antimicrobial wound gel in the International Wound Journal, highlighting the gel's wound healing properties and antimicrobial activity [1][2] Group 1: Publication and Validation - The article titled "Wound Healing Property of a Novel Thermo-Reversible Wound Gel With Lasting Antimicrobial and Antibiofilm Activity" is authored by Dr. Jeyachchandran Visvalingam and includes contributions from the University of Miami [1] - The publication in a peer-reviewed journal underscores the scientific rigor of revyve technology and provides independent validation of the gel's safety and clinical potential [3] Group 2: Product Efficacy and Features - The revyve Antimicrobial Wound Gel demonstrates efficacy against a range of wound-related pathogens, achieving a 99.99% to 99.9999% reduction in bacterial counts within 30 minutes [7] - The gel exhibits sustained in vitro activity for up to 7 days, potentially reducing the frequency of dressing changes [7] - It is designed as a thermo-reversible gel that transitions from a liquid to a gel at body temperature, allowing for easy removal [7] Group 3: Company Overview - Kane Biotech is focused on developing novel wound care treatments that target biofilms, which contribute to antibiotic resistance and adverse clinical outcomes [4] - The revyve product line, including the Antimicrobial Wound Gel and Spray, has received U.S. FDA 510(k) clearance and Health Canada approval [4]